Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
MedPage Today on MSN6d
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 InhibitorsUse of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Daily Maverick on MSN3d
New chronic kidney disease treatments show promise, but are expensive and inaccessibleWhile the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...
Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...
Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia Therapeutics’ endgame remains focused on pushing the therapy into a wide | ...
The impact of chronic kidney disease (CKD) keeps escalating around the world, and this burden is projected to rise with ...
3d
Lifestyle changes play a significant role in preventing CKD. Small changes, like reducing salt intake and staying active, can ...
Guwahati: Physicians at Gauhati Medical College and Hospital (GMCH) have flagged elevated instances of Chronic Kidney Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback